StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Abbott India Limited
NSE:ABBOTINDIA.NS
Sector
Location
Market Cap
USD 8.61 B
Share Price
USD 405.35
Avg Daily Volume
8,826
Change (1 day)
1.00%
Change (1 year)
21.33%
Change (YTD)
16.67%
Abbott India Limited Market Capitalization on July 08, 2025: USD 8.61 B
Abbott India Limited Market Capitalization is USD 8.61 B on July 08, 2025, a 21.30% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Abbott India Limited 52-week low Market Capitalization is USD 8.84 B on July 08, 2025, which is 2.67% above the current Market Capitalization.
-
Abbott India Limited 52-week low Market Capitalization is USD 6.35 B on July 08, 2025, which is -26.26% below the current Market Capitalization.
-
Abbott India Limited average Market Capitalization for the last 52 weeks is USD 7.34 B.
Competitors
Eli Lilly and Company
USD 772.87
LLY
-7.80
-1.00%
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
Cencora, Inc.
USD 302.50
COR
+6.27
2.12%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.45
600276.SS
+0.11
1.52%
Takeda Pharmaceutical Company Limited
USD 29.99
4502.T
-0.22
-0.74%
Haleon plc
USD 5.05
HLN.L
-0.10
-2.03%
Daiichi Sankyo Company, Limited
USD 21.41
4568.T
-0.29
-1.33%
UCB SA
USD 198.91
UCB.BR
+0.11
0.06%
Hansoh Pharmaceutical Group Company Limited
USD 3.95
3692.HK
-0.02
-0.47%
Key Data
| Date | Market Capitalization | Share Price | Share Price | Price to Earnings Ratio (P/E) |
|---|
Competitors
Eli Lilly and Company
USD 772.87
LLY
-7.80
-1.00%
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
Cencora, Inc.
USD 302.50
COR
+6.27
2.12%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.45
600276.SS
+0.11
1.52%
Takeda Pharmaceutical Company Limited
USD 29.99
4502.T
-0.22
-0.74%
Haleon plc
USD 5.05
HLN.L
-0.10
-2.03%
Daiichi Sankyo Company, Limited
USD 21.41
4568.T
-0.29
-1.33%
UCB SA
USD 198.91
UCB.BR
+0.11
0.06%
Hansoh Pharmaceutical Group Company Limited
USD 3.95
3692.HK
-0.02
-0.47%